Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Radiologist pipeline barely keeping pace with population growth
“Expanding residency slots and mitigating workforce attrition will be necessary to mitigate increasing workforce gaps," experts write in the Journal of the American College of Radiology.
New data raise concern about Medicare quality payment program, radiology experts say
"Topped-out" measures may not actually reflect universally high performance, a new analysis of CMS data shows.
FDA announces recall on angiography syringes after 4 serious injuries to patients
The recall is officially an early alert, as the syringes are part of surgical convenience kits—the rest of which are safe to use. The defective syringes risk causing fatal injuries to patients and must be discarded.
FDA clears first AI-enabled, detector-based spectral CT system
The Spectral CT Verida system is powered by artificial intelligence, offering users AI-enabled image reconstructions, improved noise reduction and enhanced image quality.
MGMA supports bipartisan effort to eliminate $100K visa fee for healthcare workers
MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage.

Medicare data stethoscope healthcare trends graphs finance financials

Radiologist pipeline barely keeping pace with population growth

“Expanding residency slots and mitigating workforce attrition will be necessary to mitigate increasing workforce gaps," experts write in the Journal of the American College of Radiology.

New data raise concern about Medicare quality payment program, radiology experts say

"Topped-out" measures may not actually reflect universally high performance, a new analysis of CMS data shows.

FDA announces recall on angiography syringes after 4 serious injuries to patients

The recall is officially an early alert, as the syringes are part of surgical convenience kits—the rest of which are safe to use. The defective syringes risk causing fatal injuries to patients and must be discarded.

FDA clears first AI-enabled, detector-based spectral CT system

The Spectral CT Verida system is powered by artificial intelligence, offering users AI-enabled image reconstructions, improved noise reduction and enhanced image quality.

The U.S. healthcare system is facing a deepening workforce shortage driven by policy constraints, limited training capacity and immigration barriers—issues that could significantly worsen in the coming years without reforms, according to Anders Gilberg, senior vice president, government affairs at Medical Group Management Association (MGMA), in the above video interview. #MGMA #IMMIGRATION

MGMA supports bipartisan effort to eliminate $100K visa fee for healthcare workers

MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage.

Elucid's new Lesion Analysis Tool now commercially available

New imaging AI tool hits market with reimbursement eligibility

The product, which is offered within Elucid’s novel Plaque-IQ software suite, allows physicians to analyze lesion composition and plaque burden across any vessel.

overweight patient seeking health advice

FDA links weight loss pill to ‘unexpected’ cardiovascular risks

The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects.

ACIP panel given new guidance to shape vaccine recommendations

The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.